NASDAQ: ABOS
Acumen Pharmaceuticals Inc Stock Ownership - Who owns Acumen Pharmaceuticals?

Insider buying vs selling

Have Acumen Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matt ZugaCFO Chief Business Officer2025-01-2328,902$1.72
$49.62kSell
Russell BartonChief Operating Officer2025-01-212,914$1.61
$4.69kSell
Derek M. MeisnerChief Legal Officer Corp Sec2025-01-213,418$1.59
$5.43kSell
Daniel Joseph OconnellChief Executive Officer2025-01-2112,619$1.59
$20.10kSell
Eric SiemersChief Medical Officer2025-01-213,219$1.59
$5.12kSell
Matt ZugaCFO Chief Business Officer2025-01-214,364$1.60
$6.99kSell
Eric SiemersChief Medical Officer2025-01-0310,859$1.85
$20.05kSell
Derek M. MeisnerChief Legal Officer Corp Sec2025-01-0311,122$1.84
$20.51kSell
Matt ZugaCFO Chief Business Officer2025-01-0313,235$1.84
$24.37kSell
Daniel Joseph OconnellChief Executive Officer2025-01-0347,778$1.84
$87.86kSell

1 of 2

ABOS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABOS insiders and whales buy or sell their stock.

ABOS Shareholders

What type of owners hold Acumen Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert D. Hardie6.42%3,859,141$5.60MInsider
Sands Capital Ventures Discovery Fund III LP5.69%3,417,075$4.95MInsider
Sands Capital Ventures LLC5.69%3,417,075$4.95MInstitution
Franklin Resources Inc5.45%3,273,633$4.75MInstitution
Blackrock Inc3.95%2,372,047$3.44MInstitution
Fmr LLC3.37%2,023,760$2.93MInstitution
Vanguard Group Inc3.23%1,940,771$2.81MInstitution
Rock Springs Capital Management LP3.06%1,838,916$2.67MInstitution
Knollwood Investment Advisory LLC2.71%1,628,510$2.36MInstitution
Jpmorgan Chase Co1.56%937,908$1.36MInstitution

1 of 3

ABOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABOS38.16%17.25%Net SellingNet Selling
XFOR50.93%1.93%Net SellingNet Selling
INZY53.51%46.49%Net Selling
ELTX3.91%71.92%Net BuyingNet Buying
TARA34.51%65.49%Net SellingNet Selling

Acumen Pharmaceuticals Stock Ownership FAQ

Who owns Acumen Pharmaceuticals?

Acumen Pharmaceuticals (NASDAQ: ABOS) is owned by 38.16% institutional shareholders, 17.25% Acumen Pharmaceuticals insiders, and 44.59% retail investors. Robert D. Hardie is the largest individual Acumen Pharmaceuticals shareholder, owning 3.86M shares representing 6.42% of the company. Robert D. Hardie's Acumen Pharmaceuticals shares are currently valued at $5.60M.

If you're new to stock investing, here's how to buy Acumen Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.